SARS and MERS - Industry Response to Disease Outbreak - A Case Study

Table of Contents

1 Executive Summary

• 1.1 Report Scope
• 1.2 Navigate the COVID-19 Outbreak with GlobalData Pharma’s COVID-19 Dashboard
• 1.3 Monitor the COVID-19 Outbreak with GlobalData Epidemiology Indicators

2 Epidemiology

• 2.1 Epidemiology: Snapshot as of March 25, 2020
• 2.2 Epidemiology: Disease Trajectory as of March 25, 2020
• 2.3 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in China as of March 25, 2020
• 2.4 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in Italy as of March 25, 2020
• 2.5 Epidemiology Indicators in the Top 3 Most-Affected Countries: Disease Trajectory in the US as of March 25, 2020
• 2.6 Epidemiology Forecast: United States

3 Pipeline Overview

• 3.1 Pipeline Therapeutics: Breakdown by Phase
• 3.2 Pipeline Therapeutics: Breakdown by Molecule Type
• 3.3 Pipeline Therapeutics: Breakdown by Type of Developer
• 3.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
• 3.5 Pipeline Therapeutics: Preclinical-Stage Candidates
• 3.6 Pipeline Therapeutics: Currently Available Data
• 3.7 Pipeline Vaccines: Breakdown by Phase
• 3.8 Pipeline Vaccines: Breakdown by Developer Type
• 3.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

4 Pipeline Overview

• 4.1 Pipeline Therapeutics: Breakdown by Phase
• 4.2 Pipeline Therapeutics: Breakdown by Molecule Type
• 4.3 Pipeline Therapeutics: Breakdown by Type of Developer
• 4.4 Pipeline Therapeutics: Clinical-Stage Candidates (Phase I - III)
• 4.5 Pipeline Therapeutics: Preclinical-Stage Candidates
• 4.6 Pipeline Therapeutics: Currently Available Data
• 4.7 Pipeline Vaccines: Breakdown by Phase
• 4.8 Pipeline Vaccines: Breakdown by Developer Type
• 4.9 Pipeline Vaccines: Clinical and Preclinical-Stage Candidates

5 Clinical Trials

• 5.1 Clinical Trials: Breakdown by Phase
• 5.2 Clinical Trials for Therapeutics and Vaccines
• 5.3 Clinical Trials: Overview by Region
• 5.4 Clinical Trials for Therapeutics: Leading Sponsors
• 5.5 Clinical Trials: Leading Industry Sponsors
• 5.6 Trends in Trial Design

6 Deal-making Trends

• 6.1 Deal-making Trends

7 Social Media Trends

• 7.1 Key Twitter Chatter
• 7.2 Top Trending Tweets include #Covid19 #Coronavirus #Patients #Flattenthecurve

8 Key Findings

• 8.1 Key Findings

9 Appendix

• 9.1 Sources
• 9.2 Methodology
• 9.3 About the Authors

10 About GlobalData